Anemia

Anemia is a major health problem, with nearly 2 billion people affected globally. It afflicts more people worldwide than low back pain or diabetes – or even anxiety and depression…

Exton, Pennsylvania, July 20, 2023 (GLOBE NEWSWIRE) -- Nephrologists have long awaited the approval of HIF-PH inhibitors for the treatment of anemia in their chronic kidney disease (CKD)…

Daily low-dose aspirin increased incident anemia among otherwise healthy older…

Researchers at UCL and University of Ghana have successfully predicted whether children have anaemia using only a set of smartphone images. The study, published in PLOS ONE, brought together…

The advance could make anemia screening more widely available for children in Ghana (and other low- and middle-income countries) where there are high rates of the condition due to iron…

The FDA approved the first oral agent for chronic kidney disease (CKD)-related anemia for…

Myelofibrosis treatment with the Janus kinase (JAK) inhibitor momelotinib resulted in clinically significant improvements in…

Patients with myelofibrosis had clinically significant improvement in disease-related symptoms, including anemia and spleen enlargement, when treated with the targeted therapy momelotinib,…

Continued advancement of pamrevlumab clinical trials – topline data from five pivotal Phase 3 trials beginning in 1H 2023 through mid-2024Completed enrollment of MATTERHORN Phase 3 study of…

SAN FRANCISCO, Nov. 01, 2022 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that Enrique Conterno, Chief Executive Officer, will participate in a fireside chat at the…